197A — TAUNS Laboratories Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedSmall CapNeutral

Annual balance sheet for TAUNS Laboratories, fiscal year end - June 30th, JPY millions except per share, conversion factor applied.

	2022 June 30th	2023 June 30th	2024 June 30th	2025 June 30th	2026 June 30th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	Yuho	Yuho	Yuho
Standards:	JAS	JAS	JAS	JAS	JAS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	6,347	1,244	9,425	9,267	3,564
Net Total Accounts Receivable
Net Total Receivables	942	3,481	2,723	248	9,112
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	12,036	9,457	16,916	15,477	19,265
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	3,683	4,402	7,905	12,279	15,248
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	20,268	18,332	29,261	36,515	44,621
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	8,937	6,518	10,474	9,530	15,254
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	12,912	9,842	15,595	19,098	25,200
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	7,356	8,490	13,667	17,418	19,421
Total Liabilities & Shareholders' Equity	20,268	18,332	29,261	36,515	44,621
Total Common Shares Outstanding